How has government spending on health prepared countries for tackling the Covid-19 pandemic? Arguably, spending is the primary policy tool for governments for providing effective health. Yet, much empirical evidence suggests that spending alone has little effect on health outcomes. We argue that...

We propose a novel framework to analyse the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone...

We propose a novel framework to analyse the macroeconomic impact of noncommunicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of novel coronavirus that causes Coronavirus disease 2019 (COVID-19) that generates high number of infected cases and deaths worldwide. The fundamental question in this field of research is how countries can reduce...

We discuss and review literature on the macroeconomic effects of epidemics and pandemics since the late 20th century. First, we cover the role of health in driving economic growth and well-being and discuss standard frameworks for assessing the economic burden of infectious diseases. Second, we...

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the Coronavirus Disease 2019 (COVID-19) is still circulating in 2021 with new mutations and the state of emergency remains in manifold countries. Countries have applied in 2020 nonpharmaceutical interventions to...

Using tools described in our earlier work (Hassan et al., 2019, 2020), we develop text-based measures of the costs, benefits, and risks listed firms in the US and over 80 other countries associate with the spread of Covid-19 and other epidemic diseases. We identify which firms expect to gain or...

The emergence of Covid-19 has affected all aspects of human life across the globe. Lockdowns everywhere are having dramatic social and economic consequences. No therapy has yet been approved, and vaccines are a priority potential tool to control the pandemic and its impacts. Multiple vaccines...

The coronavirus disease (COVID-19) outbreak has resulted in the death of over four million people since late 2019. To reduce the human and economic costs of COVID-19, different vac-cines have been developed and distributed across countries. There has been significant cross-country variation in...

This study quantifies the economic impacts of SARS on the four affected Asian economies and the two most affected Chinese regions using synthetic control methods with macroeconomic and remote-sensing nightlight data. For the four affected economies (China, Hong Kong, Taiwan, and Singapore), we...